![\"\"](\"https:\/\/larifan.eu\/wp-content\/uploads\/2021\/08\/LARIFAN_INJEKCIJA_002-300x212.png\")
<\/strong><\/h1>\nInformation renewed on 27.04.2021<\/p>\n
Prescription medication \u2013 usage allowed only under doctor’s recommendations<\/strong><\/h1>\nDescription<\/strong><\/p>\nSolution for injections LARIFANS 2.5 mg\/2 ml is an immunomodulating preparation with antiviral and antitumoral activity. Larifan is an interferon (IFN) inducer and the resulting biological effects may be caused by both the induced endogenous IFN and the direct activity of the dsRNA molecule.<\/p>\n
Therapeutic indications:<\/strong><\/p>\n– Recurrent herpes virus infection of any localization.<\/strong><\/p>\n\n- Secondary immunodeficiency of any origin (caused by viral infections or anti-cancer medicaments etc.)<\/strong><\/li>\n<\/ul>\n
Dosage and application:<\/p>\n
Larifan is injected subcutaneously. In case of a recurrent herpes virus infection the dose is 2.5 mg once a day, four times with 3 day intervals (1st, 5th, 9th, 12th day). Depending on the outcome , the course may be repeated after 6 months. For immunodeficiency treatment: dose rate 2.5 mg once a day, four times at weekly intervals, courses have to be repeated after a break of 1 or 2 months.<\/p>\n
Advertising is intended for health care professionals only.<\/p>\n
For full information about the medicine, see the Summary of Characteristics<\/a>.<\/p>\n <\/p>\n
For inquires\u00a0about the availability of Larifan 2.5 mg\/ 2 ml\u00a0prescription\u00a0solution for injections contact us at:<\/p>\n
GP Nord Ltd.<\/p>\n
Mob. nr. 66064140<\/p>\n
Description<\/strong><\/p>\n Solution for injections LARIFANS 2.5 mg\/2 ml is an immunomodulating preparation with antiviral and antitumoral activity. Larifan is an interferon (IFN) inducer and the resulting biological effects may be caused by both the induced endogenous IFN and the direct activity of the dsRNA molecule.<\/p>\n Therapeutic indications:<\/strong><\/p>\n – Recurrent herpes virus infection of any localization.<\/strong><\/p>\n Dosage and application:<\/p>\n Larifan is injected subcutaneously. In case of a recurrent herpes virus infection the dose is 2.5 mg once a day, four times with 3 day intervals (1st, 5th, 9th, 12th day). Depending on the outcome , the course may be repeated after 6 months. For immunodeficiency treatment: dose rate 2.5 mg once a day, four times at weekly intervals, courses have to be repeated after a break of 1 or 2 months.<\/p>\n Advertising is intended for health care professionals only.<\/p>\n For full information about the medicine, see the Summary of Characteristics<\/a>.<\/p>\n <\/p>\n For inquires\u00a0about the availability of Larifan 2.5 mg\/ 2 ml\u00a0prescription\u00a0solution for injections contact us at:<\/p>\n GP Nord Ltd.<\/p>\n Mob. nr. 66064140<\/p>\n\n